Navigation Links
AtheroNova Signs Agreement for Development of Clinical Trial Supplies
Date:4/25/2012

and a-80 bed Phase 1 Unit in Changchun, Jiling Province China.  Frontage has an AALAC certified preclinical animal facility in Pennsylvania, where it also maintains bioanalytical and CMC facilities. In Shanghai and Beijing, China, the company also operates bioanalytical and CMC facilities.  The Frontage CMC Division provide services in the areas of custom API synthesis and GMP manufacturing, analytical testing, formulation development and manufacturing of clinical trial materials including Sterile (Injection and Ophthalmic), Oral Solid (IR and CR), Topical, and High Potent products.  As a rapidly expanding CRO with ten years of success providing high-quality GXP services, Frontage has established an international standard in pharmaceutical product research, development, quality and management systems.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the Company's product shipments, suitability of the compound for its intended use, mechanisms of action, clinical trials and supply chain as well as the development of applications for AtheroNova's technology. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other infor
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Agrees With AtheroNovas Clinical Development Plan as Proposed
2. AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001
3. HealthyWomen Asks: Do You Know the Signs and Symptoms of von Willebrand Disease (VWD)?
4. Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona
5. Fortis Healthcare Signs Agreement Giving Indias Fastest-Growing Hospital Chain Access to Masimos State-of-the-Art Noninvasive Patient Monitoring Solutions
6. Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma
7. Altitude Organic New Dispensary Counter-Space Acquisition Program - Zazzz™ - Signs Premier Location
8. Universal Capital Management Signs Letter of Intent to Purchase ProShield™ Assets
9. QRxPharma Signs License and Option Agreement with Actavis
10. Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
11. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Rico , May 17, 2013  Serving a region ... Puerto Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... radiation therapy capabilities with the acquisition of an Elekta Versa ... . Versa HD offers clinicians the versatility to deliver conventional ... body, while also enabling treatment of highly complex cancers that ...
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... , NEW YORK , July 20 ... the Susquehanna International Group of Companies (SIG), announced today that ... Senior Analyst covering the Specialty Pharmaceuticals sector. Mr. Nachman, whose ... Labs , King Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott ...
... July 20 Medical Device Consultants, Inc. ... (CRO) serving the medical device and diagnostics industry, today ... Services Ltd (CDSS), a clinical services and CRO based ... clients access to the best of both organizations, core ...
Cached Medicine Technology:Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 2Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 3Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership 2Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership 3
(Date:5/19/2013)... California (PRWEB) May 19, 2013 According to ... Body Firmers” many people are self-conscious about the appearance of ... an option when diet and exercise fail to tone and ... may appeal to those looking to get the firmest ... is an effective mini-overview,” says Dr. Simon Ourian, Medical Director ...
(Date:5/19/2013)... St. Louis, MO (PRWEB) May 19, 2013 ... Member Conference, May 19-22, 2013, at the Walt Disney ... the latest trends in supply chain innovation, care delivery ... a much different dynamic in all healthcare markets, ... necessary part of the conversation,” said Todd Ebert, Amerinet ...
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic growth ... the lowest unemployment rates in the country. Forbes Magazine distinguished ... Business and Careers and it consistently scores high on many ... in the nation and is a strong business leader thanks ... Editions TV are pleased to announce air dates ...
(Date:5/19/2013)... in Minnesota have a great option to get in shape ... Fat Loss Formula. The best part is people can ... The product sells for $135 dollars and is an immediate ... http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. People may ... the 28 Day Fat Loss Formula they will be happy ...
(Date:5/19/2013)... 2013 In partnership with the medical practice ... the launch of an SEO website for dentists. The purpose ... in Google. , http://www.e-dentists.com/ , A perk to ... service until they see results. Dentists can request the keywords ... run by JD Media Surge, LLC rank high for competitive ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2
... According to a new federal report, in spite of the ... several new programs to overcome it//, the efficacy of these ... efforts need national leadership, according to the report, Progress in ... Institute of Medicine. This report was released yesterday. ...
... revealed that there is a “crisis” over lack of donors at ... clinics being totally out of stock//, women and couples wanting to ... the highest number of donors was 459. Ever since, the number ... law was passed that gave kids the right to know the ...
... week the distribution of a drug to help fight an ... is being affected by an extremely virulent strain of tuberculosis, ... the country. The health officials have now promised that they ... week to help fight the disease. The officials but also ...
... for an extensive study for the evaluation of the possible ... stents. // ,Stents are widely used heart devices ... had essentially eliminated short-term restenosis as a complication of coronary ... cloud for possible late-term risks. Reports indicate that almost 6 ...
... unique way to curb binge drinking, researchers say parents should allow ... youngsters // to drink at parties and at home may be ... ,Professor Mark Bellis, the author of the report said that children ... and allowed to drink with them were sensible in their approach ...
... a safe way to monitor the fate of transplanted ... issue of the journal Diabetes. // Researchers from the ... (MGH) said that they were able to track transplanted ... human transplants. ,"Clinical trials and animal studies ...
Cached Medicine News:Health News:Slow Fight Against Childhood Obesity 2Health News:Slow Fight Against Childhood Obesity 3Health News:Shortage of donors at sperm bank clinics 2Health News:South Africa To Make Available Two New Drugs To Fight The TB Outbreak 2Health News:MRI Can Monitor Transplanted Islets 2
... (Low Melt), A low temperature agarose ... temperature , Optimal for in-gel restriction digestion/ligation ... a very manageable clear gel that provides ... at approximately 65°C and remains fluid at ...
... Molecular Biology Grade, is used ... nucleic acids. It can be ... from 0.2 to 40 kb., ... is tested and certified to ...
... UltraPure™ Agarose 1000 is specifically formulated for ... PCR fragments <1000 bp. This standard melting ... as little as 10 bp difference in ... a strong gel structure for better handling ...
Agarose IEF is suitable for isoelectric focusing of large molecules and is the gel of choice for many IEF applications and immunochemical detection methods....
Medicine Products: